Studies on the Mechanism of the Venoconstrictor Activity of Ergotamine on Isolated Canine Saphenous Veins
Else Müller‐Schweinitzer, E. Stürmer
Abstract
Else Müller‐Schweinitzer, E. Stürmer
Abstract
Ergotamine stimulates spiral strips from dog saphenous veins in concentrations about 2,000 times lower than that of noradrenaline, but its maximal effect is only 20% compared to that of noradrenaline. Phentolamine antagonizes the ergotamine effects. The pA2 value for phentolamine against ergotamine is 6.94, and for phentolamine against noradrenaline it is 6.96. Cocaine potentiates noradrenaline effects but does not change ergotamine effects. The results suggest that the venoconstrictor activity of ergotamine is mediated mainly via stimulation of α-adrenoceptors.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ergotamine stimulates spiral strips from dog saphenous veins in concentrations about 2,000 times lower than that of noradrenaline, but its maximal effect is only 20% compared to that of noradrenaline. Phentolamine antagonizes the ergotamine effects. The pA2 value for phentolamine against ergotamine is 6.94, and for phentolamine against noradrenaline it is 6.96. Cocaine potentiates noradrenaline effects but does not change ergotamine effects. The results suggest that the venoconstrictor activity of ergotamine is mediated mainly via stimulation of α-adrenoceptors.
Key concepts: Ergotamine, Phentolamine, Internal medicine, Endocrinology, Chemistry, Stimulation, Medicine, Migraine